Sonnet BioTherapeutics Holdings, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Sonnet BioTherapeutics Holdings, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q3 2025

Aug 13, 2025

Quarterly report10-Q

Q2 2025

May 13, 2025

Quarterly report10-Q

Q1 2025

Feb 13, 2025

Quarterly report10-Q

Earnings release8-K

Investor Presentation

Jan 28, 2025

Slides

2024

Q4 2024

Dec 17, 2024

Earnings release8-K

Q3 2024

Aug 14, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

May 14, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

Feb 14, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Dec 14, 2023

Earnings release8-K

Q3 2023

Aug 14, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

May 10, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

Feb 13, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Dec 15, 2022

Earnings release8-K

Q3 2022

Aug 15, 2022

Earnings release8-K

Q2 2022

May 10, 2022

Quarterly report10-Q

Earnings release8-K

Q1 2022

Feb 8, 2022

Quarterly report10-Q

Earnings release8-K